Search
for
Sort by
Research 931–960 of 1000+
- Antiandrogen Therapy for Skin and Hair Disease
- What is the Rationale for Androgen Therapy for Women?
- Topical minoxidil in the treatment of alopecia areata.
- Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss
- Female Androgenic Alopecia
- Short anagen syndrome: Case series and literature review
- Hair loss with levetiracetam in five patients with epilepsy
- Isoniazid-induced alopecia
- Cicatricial (scarring) alopecia
- The effects of topical diazoxide on hair follicular growth and physiology of the stumptailed macaque
- An inherited nail dystrophy principally affecting the great toenails
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Pinnal Diseases
- Salivary testosterone levels in infertile men
- Clinical, Microscopic and Ultrastructural Findings in a Case of Short Anagen Syndrome
- A practical approach to feline symmetrical alopecia
- Caution with Hair Dye: Foreign Body Skull Erosive Granuloma from Exogenous Hair Pigmentation
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Prominent follicular mucinosis with diffuse scalp alopecia resembling alopecia areata
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Unilateral nevoid hyperkeratosis of the nipple and areola in a Saudi female
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Phototherapy of androgenetic alopecia with low level narrow band 655-nm red light and 780-nm infrared light
- Reply
- Platelet Immune Interactions, Lifespan, and Senescence
- Iraqi Women with Hirsutism, Clinical and Biochemical Characteristics: Retrospective Study
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- ALOPECIA AREATA-A CLINICAL ANALYSIS
- The lowest effective dose of botulinum toxin in detrusor sphincter dyssynergia